Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,617 across all filing types
Latest filing 2021-07-09 Regulatory Filings
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
110年6月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 景岳, providing information about fund loans and endorsement guarantees for the current and previous months, with amounts all zero. The content is very short (601 characters) and consists mainly of tabular data about financial guarantees and loans, without detailed financial statements or analysis. It does not contain any narrative, management discussion, or comprehensive financial data. It appears to be a regulatory disclosure or compliance update rather than a full report. Given the short length and nature of the content, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-07-09 Chinese
110年06月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, their spouses, and minor children, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on insider share transactions and holdings rather than financial results, management changes, or other corporate filings. There is no indication of a full financial report, earnings release, or meeting materials. The document is a report of personal share transactions and holdings by company directors and executives, fitting the definition of Director's Dealing filings.
2021-07-07 Chinese
110年06月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed information about shareholdings and pledged shares of company insiders, including directors and management. It lists share counts, pledge ratios, and relationships, which corresponds to disclosures about insider share transactions or holdings. There is no indication of financial results, meeting materials, or regulatory announcements. The content matches the definition of Director's Dealing, which reports personal share transactions by company directors and executives.
2021-07-07 Chinese
公告本公司申請股票上櫃轉上市時所出具之承諾事項 暨其後續執行情形
Regulatory Filings Classification · 95% confidence The document is a short announcement (768 characters) from a company regarding its commitments and subsequent execution related to its application for stock listing transfer from OTC to main board. It references compliance with a regulatory letter from the Taiwan Stock Exchange and reports on the status of audit-related commitments as of a certain date. There are no financial statements or detailed financial data presented, only a status update on compliance and commitments. The document is an official regulatory announcement about company compliance and status, not a full report or financial statement. Given the short length and nature, it fits best under Regulatory Filings (RNS) as a general compliance announcement rather than a full audit report or financial report.
2021-07-07 Chinese
110年6月22日內部人設質解質
Director's Dealing Classification · 95% confidence The document is a short tabular report showing a pledge of shares by a company director (黃國杰) with details on the number of shares pledged and the pledgee. It includes company code, names, dates, and share counts. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives. The document length is very short (325 characters), and it is not an announcement of a report but the actual data. Therefore, the classification is DIRS with high confidence.
2021-06-23 Chinese
110年5月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 景岳, reporting on the status of fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It contains no detailed financial statements, no management discussion, no audit information, no voting results, no legal proceedings, and no mention of any report publication or meeting. The content is a regulatory disclosure of financial status related to guarantees and loans, typical of a regulatory filing or compliance announcement. The document length is very short (601 characters), and it does not contain or reference any full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2021-06-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.